Skip to main content
Erschienen in: European Radiology 3/2023

14.10.2022 | Cardiac

Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis

verfasst von: Yan Gao, Hai-Peng Wang, Meng-Xiao Liu, Hui Gu, Xian-Shun Yuan, Jumatay Biekan, Xi-Ming Wang

Erschienen in: European Radiology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To analyze myocardial fibrosis in dilated cardiomyopathy (DCM) patients with no late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) using T1 mapping and extracellular volume (ECV) and investigate the potential correlation with left ventricular (LV) dilation and dysfunction.

Methods

The study included 41 DCM patients without LGE and 79 healthy controls. T1 and ECV were compared between the two groups using multivariable logistic regression analysis. The correlations between histological and functional parameters were evaluated using Pearson’s correlation.

Results

Mean native myocardial T1 and ECV were significantly higher in the DCM group compared to controls (p ≤ 0.001, respectively). Multivariable logistic regression revealed that ECV (mean, minimum), LV ejection fraction (LVEF), and LV end-diastolic diameter (LVEDD) were independent discriminators for LGE-negative DCM; the area under the curve (AUC) of LVEF, LVEDD, ECV mean, and ECV minimum were 0.97, 0.96, 0.88, and 0.68, respectively. In the DCM group, LVEDD and LVEF were positively and negatively correlated with ECV, respectively. LVEDV index and LV end-systolic volume (LVESV) index were positively correlated with native-T1 and ECV, and the absolute value of LV global strain had a negative correlation with ECV.

Conclusions

Early myocardial fibrosis in DCM could be detected by prolonged native T1 and elevated ECV despite the absence of LGE on CMR. Moreover, the change of histological characteristics of myocardium in DCM was correlated with LV dilation and dysfunction.

Key Points

At an early stage, patients with DCM may have myocardial fibrosis despite the absence of LGE.
T1 mapping and ECV are efficient methods for early detection of potential myocardial fibrosis.
Increased native T1 and ECV are correlated with left ventricular dilation and dysfunction in LGE-negative DCM patients.
Literatur
1.
Zurück zum Zitat Donal E, Delgado V, Bucciarelli-Ducci C et al (2019) Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 20:1075–1093CrossRefPubMed Donal E, Delgado V, Bucciarelli-Ducci C et al (2019) Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 20:1075–1093CrossRefPubMed
2.
3.
Zurück zum Zitat Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816CrossRefPubMed Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816CrossRefPubMed
4.
5.
Zurück zum Zitat Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124:1035–1045CrossRefPubMed Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124:1035–1045CrossRefPubMed
6.
Zurück zum Zitat Brown PF, Miller C, Di Marco A, Schmitt M (2019) Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy. Heart 105:270–275CrossRefPubMed Brown PF, Miller C, Di Marco A, Schmitt M (2019) Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy. Heart 105:270–275CrossRefPubMed
7.
Zurück zum Zitat Mordi I, Carrick D, Bezerra H, Tzemos N (2016) T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803CrossRefPubMed Mordi I, Carrick D, Bezerra H, Tzemos N (2016) T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803CrossRefPubMed
8.
Zurück zum Zitat Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896–908CrossRefPubMed Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896–908CrossRefPubMed
9.
Zurück zum Zitat Masci PG, Doulaptsis C, Bertella E et al (2014) Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail 7:448–456CrossRefPubMed Masci PG, Doulaptsis C, Bertella E et al (2014) Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail 7:448–456CrossRefPubMed
10.
Zurück zum Zitat Neilan TG, Coelho-Filho OR, Danik SB et al (2013) CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 6:944–954CrossRefPubMedPubMedCentral Neilan TG, Coelho-Filho OR, Danik SB et al (2013) CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 6:944–954CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59CrossRefPubMed McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59CrossRefPubMed
12.
Zurück zum Zitat Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903CrossRefPubMed Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903CrossRefPubMed
13.
Zurück zum Zitat Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18:89CrossRefPubMedPubMedCentral Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18:89CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144CrossRefPubMed Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144CrossRefPubMed
15.
Zurück zum Zitat Xu J, Zhuang B, Sirajuddin A et al (2020) MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology 294:275–286CrossRefPubMed Xu J, Zhuang B, Sirajuddin A et al (2020) MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology 294:275–286CrossRefPubMed
16.
Zurück zum Zitat aus dem Siepen F, Buss SJ, Messroghli D et al (2015) T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16:210-216 aus dem Siepen F, Buss SJ, Messroghli D et al (2015) T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16:210-216
17.
Zurück zum Zitat Dass S, Suttie JJ, Piechnik SK et al (2012) Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5:726–733CrossRefPubMed Dass S, Suttie JJ, Piechnik SK et al (2012) Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 5:726–733CrossRefPubMed
18.
Zurück zum Zitat Pinto YM, Elliott PM, Arbustini E et al (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37:1850–1858CrossRefPubMed Pinto YM, Elliott PM, Arbustini E et al (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37:1850–1858CrossRefPubMed
19.
Zurück zum Zitat Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2013) Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 15:91CrossRefPubMedPubMedCentral Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2013) Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 15:91CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Xue H, Kellman P, Larocca G, Arai AE, Hansen MS (2013) High spatial and temporal resolution retrospective cine cardiovascular magnetic resonance from shortened free breathing real-time acquisitions. J Cardiovasc Magn Reson 15:102CrossRefPubMedPubMedCentral Xue H, Kellman P, Larocca G, Arai AE, Hansen MS (2013) High spatial and temporal resolution retrospective cine cardiovascular magnetic resonance from shortened free breathing real-time acquisitions. J Cardiovasc Magn Reson 15:102CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kellman P, Larson AC, Hsu LY et al (2005) Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 53:194–200CrossRefPubMedPubMedCentral Kellman P, Larson AC, Hsu LY et al (2005) Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 53:194–200CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRefPubMed Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRefPubMed
23.
Zurück zum Zitat Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 22:19CrossRefPubMedPubMedCentral Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 22:19CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35CrossRefPubMedPubMedCentral Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed
26.
27.
Zurück zum Zitat Li S, Zhou D, Sirajuddin A et al (2022) T1 mapping and extracellular volume fraction in dilated cardiomyopathy: a prognosis study. JACC Cardiovasc Imaging 15:578–590CrossRefPubMed Li S, Zhou D, Sirajuddin A et al (2022) T1 mapping and extracellular volume fraction in dilated cardiomyopathy: a prognosis study. JACC Cardiovasc Imaging 15:578–590CrossRefPubMed
28.
Zurück zum Zitat Liang YD, Xu YW, Li WH et al (2020) Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping. J Cardiovasc Magn Reson 22:2CrossRefPubMedPubMedCentral Liang YD, Xu YW, Li WH et al (2020) Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping. J Cardiovasc Magn Reson 22:2CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Nakamori S, Dohi K, Ishida M et al (2018) Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11:48–59CrossRefPubMed Nakamori S, Dohi K, Ishida M et al (2018) Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11:48–59CrossRefPubMed
30.
Zurück zum Zitat Arheden H, Saeed M, Higgins CB et al (2000) Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215:520–528CrossRefPubMed Arheden H, Saeed M, Higgins CB et al (2000) Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215:520–528CrossRefPubMed
31.
Zurück zum Zitat Puntmann VO, Carr-White G, Jabbour A et al (2016) T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9:40–50CrossRefPubMed Puntmann VO, Carr-White G, Jabbour A et al (2016) T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 9:40–50CrossRefPubMed
32.
Zurück zum Zitat Masci PG, Schuurman R, Andrea B et al (2013) Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6:790–799CrossRefPubMed Masci PG, Schuurman R, Andrea B et al (2013) Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6:790–799CrossRefPubMed
33.
Zurück zum Zitat Kellman P, Wilson JR, Xue H et al (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14:64CrossRefPubMedPubMedCentral Kellman P, Wilson JR, Xue H et al (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14:64CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Tayal U, Wage R, Newsome S et al (2020) Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study. Eur J Heart Fail 22:1160–1170CrossRefPubMed Tayal U, Wage R, Newsome S et al (2020) Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study. Eur J Heart Fail 22:1160–1170CrossRefPubMed
35.
Zurück zum Zitat Hong YJ, Park CH, Kim YJ et al (2015) Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging 31(Suppl 1):115–122CrossRefPubMed Hong YJ, Park CH, Kim YJ et al (2015) Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging 31(Suppl 1):115–122CrossRefPubMed
37.
Zurück zum Zitat Cui Y, Chen Y, Cao Y et al (2019) Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients. Clin Radiol 74:732.e9–732.e6CrossRefPubMed Cui Y, Chen Y, Cao Y et al (2019) Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients. Clin Radiol 74:732.e9–732.e6CrossRefPubMed
38.
Zurück zum Zitat Görmeli CA, Özdemir ZM, Kahraman AS, Yağmur J, Özdemir R, Çolak C (2017) The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI. Radiol Med 122:106–112CrossRefPubMed Görmeli CA, Özdemir ZM, Kahraman AS, Yağmur J, Özdemir R, Çolak C (2017) The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI. Radiol Med 122:106–112CrossRefPubMed
39.
Zurück zum Zitat Peng WL, Zhang TJ, Shi K et al (2022) Automatic machine learning based on native T1 mapping can identify myocardial fibrosis in patients with hypertrophic cardiomyopathy. Eur Radiol 32:1044–1053CrossRefPubMed Peng WL, Zhang TJ, Shi K et al (2022) Automatic machine learning based on native T1 mapping can identify myocardial fibrosis in patients with hypertrophic cardiomyopathy. Eur Radiol 32:1044–1053CrossRefPubMed
40.
Zurück zum Zitat Jerosch-Herold M, Sheridan DC, Kushner JD et al (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–h1242CrossRefPubMedPubMedCentral Jerosch-Herold M, Sheridan DC, Kushner JD et al (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–h1242CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Shao XN, Jin YN, Sun YJ, Zhang WB, Cheng JL (2020) Evaluation of the correlation between myocardial fibrosis and ejection fraction in dilated cardiomyopathy using magnetic resonance T1 mapping. Eur Rev Med Pharmacol Sci 24:12300–12305PubMed Shao XN, Jin YN, Sun YJ, Zhang WB, Cheng JL (2020) Evaluation of the correlation between myocardial fibrosis and ejection fraction in dilated cardiomyopathy using magnetic resonance T1 mapping. Eur Rev Med Pharmacol Sci 24:12300–12305PubMed
42.
Zurück zum Zitat Jin C, Weber J, Singh H, Gliganic K, Cao JJ (2021) The association of reduced left ventricular strains with increased extracellular volume and their collective impact on clinical outcomes. J Cardiovasc Magn Reson 23:93CrossRefPubMedPubMedCentral Jin C, Weber J, Singh H, Gliganic K, Cao JJ (2021) The association of reduced left ventricular strains with increased extracellular volume and their collective impact on clinical outcomes. J Cardiovasc Magn Reson 23:93CrossRefPubMedPubMedCentral
Metadaten
Titel
Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis
verfasst von
Yan Gao
Hai-Peng Wang
Meng-Xiao Liu
Hui Gu
Xian-Shun Yuan
Jumatay Biekan
Xi-Ming Wang
Publikationsdatum
14.10.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 3/2023
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-09147-x

Weitere Artikel der Ausgabe 3/2023

European Radiology 3/2023 Zur Ausgabe

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.